The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100

Bibliographic Information

Title
The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
Author
Tsutomu Murakami

Journal

Related Projects

See more

Details

  • CRID
    1010282257024441481
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top